NUTM1 and carcinoma: A subsequently performed NUT immunohistochemistry (Fig. 3E) showed a matching “speckled type” positivity in the majority of the carcinoma cells (almost 100% in both, basaloid and more differentiated components), corroborating the diagnosis and visualizing the fusion product.